Instil Bio to Participate in the 2025 Jefferies Global Healthcare Conference

Rhea-AI Summary

Instil Bio (Nasdaq: TIL), a clinical-stage biopharmaceutical company developing novel therapies, announced its participation in the upcoming Jefferies Global Healthcare Conference. CEO Bronson Crouch will deliver a presentation on Thursday, June 5, 2025, at 4:20 PM ET. Interested parties can access a live webcast of the presentation through the provided weblink. This conference participation represents an opportunity for Instil Bio to showcase its pipeline and developments to the investment community.

News Market Reaction – TIL

-11.20%

1 alert

-11.20% News Effect

On the day this news was published, TIL declined 11.20%, reflecting a significant negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

DALLAS, May 30, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (Nasdaq: TIL, "Instil"), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today announced that Bronson Crouch, Chief Executive Officer, will present at the Jefferies Global Healthcare Conference at 4:20PM ET on Thursday, June 5, 2025. A live webcast will be available using this weblink: https://wsw.com/webcast/jeff319/til/1708376.

About Instil Bio
Instil Bio is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. Instil's lead asset, AXN-2510, is a novel and differentiated PD-L1xVEGF bispecific antibody in development for the treatment of multiple solid tumors. For more information, visit www.instilbio.com.

Forward-Looking Statements
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements do not constitute guarantees of future performance, and you are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements speak only as the date hereof, and Instil disclaims any obligation to update these statements except as may be required by law.

Contacts:
Investor Relations:
1-972-499-3350
investorrelations@instilbio.com

FAQ

When is Instil Bio (TIL) presenting at the Jefferies Healthcare Conference 2025?

Instil Bio will present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 4:20 PM ET.

Who will represent Instil Bio (TIL) at the Jefferies Healthcare Conference 2025?

Bronson Crouch, Chief Executive Officer of Instil Bio, will present at the conference.

How can I watch Instil Bio's (TIL) presentation at the Jefferies Conference?

A live webcast of the presentation will be available through the weblink: https://wsw.com/webcast/jeff319/til/1708376

What type of company is Instil Bio (TIL)?

Instil Bio is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies.